TOPICAL MENTHOL FOR TEAR SECRETION
Launched by REINHOLD VIETH · Jul 30, 2025
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring whether menthol vapor can help increase tear production in people with healthy or mildly dry eyes. Tears are important because they keep our eyes moist and comfortable, and sometimes eyes don’t make enough tears to stay properly hydrated. The study will test if applying a menthol solution to the cheek releases menthol vapor that stimulates special cold sensors on the surface of the eye, which might then trigger the eyes to produce more tears naturally.
The trial is looking for adults aged 65 to 74 who do not currently see an eye doctor for dry eye treatment. People who are allergic to menthol, wear contact lenses during the test, already have tears in their eyes before the test, recently used eye drops, or have skin problems near the application area won’t be eligible. If you participate, you can expect a simple and quick procedure where menthol is applied to your cheek, and the researchers will observe whether your eyes produce more tears. If successful, this study could lead to new, easy ways to help people keep their eyes comfortable without relying on eye drops.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Not under care of an opthalmologist for treatment of dry-eyes
- Exclusion Criteria:
- • • Excluded if "Yes" to any of the questions below.
- • Are you allergic to menthol or to menthol-containing products like tooth paste or certain cold remedies?
- • Are you wearing contact lenses during the time of testing? ________
- • Are there tears present prior to applying the menthol? ________
- • Did you use of eye drops during the hour before participation? ________
- • Do you have broken, irritated, sensitive skin and/or acne at or around application site? ________
- • Do you have a history of atopy, allergic diseases at the skin of your cheeks?
- • Do you have Stevens-Johnson syndrome, which is any known skin response to chemical, thermal, or radiation injury to the application area? ____
About Reinhold Vieth
Reinhold Vieth is a distinguished clinical trial sponsor known for his expertise in vitamin D research and metabolic bone diseases. With a strong background in medical science and a focus on nutritional health, Vieth leads studies aimed at advancing the understanding of vitamin D’s role in human health and disease prevention. His work contributes significantly to evidence-based clinical practices and the development of therapeutic strategies targeting bone metabolism and related disorders.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported